ABEONA THERAPEUTICS INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Abeona Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Abeona Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $3.79M, a 19.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.79M -$896K -19.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $4.02M -$891K -18.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $4.22M -$882K -17.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.46M -$876K -16.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $4.69M -$1.95M -29.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.92M -$2.03M -29.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.1M -$2.44M -32.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.33M -$4.07M -43.3% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $6.64M +$431K +6.94% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $6.94M +$454K +7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $7.54M +$776K +11.5% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $9.4M +$2.37M +33.7% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $6.21M -$1.09M -14.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $6.49M -$1.06M -14.1% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $6.76M -$1.04M -13.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $7.03M -$1.02M -12.6% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $7.3M -$991K -12% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $7.55M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $7.8M -$1.1M -12.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $8.05M -$853K -9.58% Dec 31, 2019 10-K 2021-03-24
Q3 2019 $8.29M Sep 30, 2019 10-Q 2019-11-12
Q1 2019 $8.9M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $8.9M Jan 1, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.